Effect of tocopherol supplementation during last trimester of pregnancy on mRNA abundances of interleukins and angiogenesis in ovine placenta and uterus

Reproductive Biology and Endocrinology

Volumn 10, Issue , 2012, Pages

  Kasimanickam, Ramanathan K ^a   Kasimanickam, Vanmathy R ^a   Haldorson, Gary J ^a   Tibary, Ahmed ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; CYTOKINE; GAMMA TOCOPHEROL; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; PLACEBO; SOLUBLE FLT1 RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; INTERLEUKIN DERIVATIVE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; EWE; FEMALE; NONHUMAN; PLACENTA; THIRD TRIMESTER PREGNANCY; UTERUS; ANIMAL; BREEDING; DRUG EFFECT; GENETICS; METABOLISM; PREGNANCY; SHEEP;

OVIS;

ALPHA-TOCOPHEROL; ANIMALS; FEMALE; GAMMA-TOCOPHEROL; INTERLEUKIN-6; INTERLEUKIN-8; INTERLEUKINS; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTA; PREGNANCY; PREGNANCY, ANIMAL; RNA, MESSENGER; SHEEP, DOMESTIC; TUMOR NECROSIS FACTOR-ALPHA; UTERUS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84856061014     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-10-4     Document Type: Article

References (58)

1. Folkman J, Klagsbrun M. Angiogenic factors. Science 1987, 235:442-447. 10.1126/science.2432664, 2432664.
2. Reynolds LP, Borowicz PP, Vonnahme KA, Johnson ML, Grazul-Bilska AT, Redmer DA, Caton JS. Placental angiogenesis in sheep models of compromised pregnancy. J Physiol 2005, 15:43-58.
3. Borowicz PP, Arnold DR, Johnson ML, Grazul-Bilska AT, Redmer DA, Reynolds LP. Placental growth throughout the last two thirds of pregnancy in sheep: vascular development and angiogenic factor expression. Biol Reprod 2007, 76:259-267. 10.1095/biolreprod.106.054684, 17050858.
4. Sherer DM, Abulafia O. Angiogenesis during implantation, and placental and early embryonic development. Placenta 2001, 22:1-13. 10.1053/plac.2000.0588, 11162347.
5. Zygmunt M, Herr F, Munstedt K, Lang U, Liang OD. Angiogenesis and vasculogenesis in pregnancy. Eur J Obstet Gynecol Reprod Biol 2003, 110:S10-S18.
6. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31. 10.1038/nm0195-27, 7584949.
7. Gerhardt H, Golding M, Fruttiger M, Ruhrberg C, Lundkvist A, Abramsson A, Jeltsch M, Mitchell C, Alitalo K, Shima D, Betsholtz C. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003, 161:1163-1177. 10.1083/jcb.200302047, 2172999, 12810700.
8. Cheung CY, Singh M, Ebaugh MJ, Brace RA. Vascular endothelial growth factor gene expression in ovine placenta and fetal membranes. Am J Obstet Gynecol 1995, 173:753-759. 10.1016/0002-9378(95)90335-6, 7573238.
9. Park JE, Chen HH, Winer J, Houck KA, Ferrara N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 1994, 269:25646-25654.
10. Kasimanickam RK, Kasimanickam VR, Rodriguez JS, Pelzer KD, Sponenberg PD, Thatcher CD. Tocopherol induced angiogenesis in placental vascular network in late pregnant ewes. Reprod Biol Endocrinol 2010, 8:86. 10.1186/1477-7827-8-86, 2913989, 20624307.
11. de Vrijer B, Davidsen ML, Wilkening RB, Anthony RV, Regnault TR. Altered placental and fetal expression of IGFs and IGF-binding proteins associated with intrauterine growth restriction in fetal sheep during early and mid-pregnancy. Pediatr Res 2006, 60:507-512. 10.1203/01.PDR.0000242364.78002.71, 16966353.
12. Plouet J, Moukadiri H. Characterization of the receptor to vasculotropin on bovine adrenal cortex-derived capillary endothelial cells. J Biol Chem 1990, 265:22071-22074.
13. Wolff B, Burns AR, Middleton J, Rot A. Endothelial cell "memory" of inflammatory stimulation: human venular endothelial cells store interleukin 8 in Weibel-Palade bodies. J Exp Med 1998, 188:1757-1762. 10.1084/jem.188.9.1757, 2212526, 9802987.
14. Utgaard JO, Jahnsen FL, Bakka A, Brandtzaeg P, Haraldsen G. Rapid secretion of prestored interleukin 8 from Weibel-Palade bodies of microvascular endothelial cells. J Exp Med 1998, 188:1751-1756. 10.1084/jem.188.9.1751, 2212514, 9802986.
15. Salcedo R, Resau JH, Halverson D, Hudson EA, Dambach M, Powell D, Wasserman K, Oppenheim JJ. Differential expression and responsiveness of chemokine receptors (CXCR1-3) by human microvascular endothelial cells and umbilical vein endothelial cells. FASEB J 2000, 14:2055-2064. 10.1096/fj.99-0963com, 11023990.
16. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Elner VM, Elner SG, Strieter RM. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992, 258:1798-1801. 10.1126/science.1281554, 1281554.
17. Strieter RM, Kunkel SL, Elner VM, Martonyi CL, Koch AE, Polverini PJ, Elner SG. Interleukin-8. A corneal factor that induces neovascularization. Am J Pathol 1992, 141:1279-1284. 1886757, 1281615.
18. Li A, Dubey S, Varney ML, Dave BJ, Singh RK. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 2003, 170:3369-3376.
19. Kamimura D, Ishihara K, Hirano T. IL-6 signal transduction and its physiological roles: the signal orchestration model. Rev Physiol Biochem Pharmacol 2003, 149:1-38.
20. Taga T, Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immuno 1997, 15:797-819.
21. Fan Y, Ye J, Shen F, Zhu Y, Yeghiazarians Y, Zhu W, Chen Y, Lawton MT, Young WL, Yang GY. Interleukin-6 stimulates circulating blood-derived endothelial progenitor cell angiogenesis in vitro. J Cereb Blood Flow Metab 2008, 28:90-98. 10.1038/sj.jcbfm.9600509, 2581498, 17519976.
22. Jauniaux E, Beatrice Gulbis B, Schandene L, Collette J, Hustin J. Distribution of interleukin-6 in maternal and embryonic tissues during the first trimester. Mol Hum Reprod 1996, 2:239-243. 10.1093/molehr/2.4.239, 9238686.
23. Fee D, Grzybicki D, Dobbs M, Ihyer S, Clotfelter J, Macvilay S, Hart MN, Sandor M, Fabry Z. Interleukin 6 promotes vasculogenesis of murine brain microvessel endothelial cells. Cytokine 2000, 12:655-665. 10.1006/cyto.1999.0599, 10843741.
24. Hernandez-Rodriguez J, Segarra M, Vilardell C, Sanchez M, Garcia-Martinez A, Esteban MJ, Grau JM, Urbano-Marquez A, Colomer D, Kleinman HK, Cid MC. Elevated production of interleukin-6 is associated with a lower incidence of disease-related ischemic events in patients with giant-cell arteritis: angiogenic activity of interleukin-6 as a potential protective mechanism. Circulation 2003, 107:2428-2434. 10.1161/01.CIR.0000066907.83923.32, 12742994.
25. Banerjee K, Biswas PS, Kim B, Lee S, Rouse BT. CXCR2-/-mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. J Immunol 2004, 172:1237-1245.
26. Huang SP, Wu MS, Shun CT, Wang HP, Lin MT, Kuo ML, Lin JT. Interleukin-6 increases vascular endothelial growth factor and angiogenesis in gastric carcinoma. J Biomed Sci 2004, 11:517-527. 10.1007/BF02256101, 15153787.
27. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y, Dinarello CA, Apte RN. IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 2003, 100:2645-2650. 10.1073/pnas.0437939100, 151394, 12598651.
28. Zhang B, Tanaka J, Yang L, Yang L, Sakanaka M, Hata R, Maeda N, Mitsuda N. Protective effect of vitamin E against focal brain ischemia and neuronal death through induction of target genes of hypoxia-inducible factor-1. Neuroscience 2004, 126:433-440. 10.1016/j.neuroscience.2004.03.057, 15207361.
29. Junovich G, Dubinsky V, Gentile T, Sarto A, Pasqualini S, Gutiérrez G. Comparative immunological effect of anticoagulant and antioxidant therapy in the prevention of abortion in mice. Am J Reprod Immunol 2011, 65:104-109. 10.1111/j.1600-0897.2010.00896.x, 20645940.
30. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408. 10.1006/meth.2001.1262, 11846609.
31. Waugh JJD, Wilson C. The interleukin-8 pathway in cancer. Clin Cancer Res 2008, 14:6735-6741. 10.1158/1078-0432.CCR-07-4843, 18980965.
32. Schraufstatter IU, Trieu K, Zhao M, Rose DM, Terkeltaub RA, Burger M. IL-8 mediated cell migration in endothelial cells depends on cathepsin B activity and transactivation of the epidermal growth factor receptor. J Immunol 2003, 171:6714-6722.
33. Petreaca ML, Yao M, Lui Y, Defea K, Martins-Green M. Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability. Mol Biol Cell 2007, 18:5014-5023. 10.1091/mbc.E07-01-0004, 2096609, 17928406.
34. Yao JS, Zhai W, Fan Y, Lawton MT, Barbaro NM, Young WL, Yang GY. Interleukin-6 upregulates expression of KDR and stimulates proliferation of human cerebrovascular smooth muscle cells. J Cereb Blood Flow Metab 2007, 27:510-520. 10.1038/sj.jcbfm.9600365, 16820800.
35. Yao JS, Zhai W, Young WL, Yang GY. Interleukin-6 triggers human cerebral endothelial cells proliferation and migration: the role for KDR and MMP-9. Biochem Biophys Res Commun 2006, 342:1396-1404. 10.1016/j.bbrc.2006.02.100, 16516857.
36. Fliser D, Buchholz K, Haller H. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation 2004, 110:1103-1107. 10.1161/01.CIR.0000140265.21608.8E, 15313950.
37. Manabe S, Okura T, Watanabe S, Fukuoka T, Higaki J. Effects of angiotensin II receptor blockade with valsartan on pro-inflammatory cytokines in patients with essential hypertension. J Cardiovasc Pharmacol 2005, 46:735-739. 10.1097/01.fjc.0000185783.00391.60, 16306795.
38. Vázquez-Oliva G, Fernández-Real JM, Zamora A, Vilaseca M, Badimón L. Lowering of blood pressure leads to decreased circulating interleukin-6 in hypertensive subjects. J Hum Hypertens 2005, 19:457-462. 10.1038/sj.jhh.1001845, 15759024.
39. Gadonski G, LaMarca BB, Sullivan E, Bennett W, Chandler D, Granger JP. Hypertension produced by reductions in uterine perfusion in the pregnant rat: role of interleukin 6. Hypertension 2006, 48:711-716. 10.1161/01.HYP.0000238442.33463.94, 16940225.
40. Orshal JM, Khalil RA. Interleukin-6 impairs endothelium-dependent NO-cGMP-mediated relaxation and enhances contraction in systemic vessels of pregnant rats. Am J Physiol Regul Integr Comp Physiol 2004, 286:R1013-R1023. 10.1152/ajpregu.00729.2003, 15142856.
41. Agarwal R, Loganath A, Roy AC, Wong YC, Lindoff C, Ng SC. Increased expression of interleukin 6 in term compared to the first trimester human placental villi. Horm Metab Res 2000, 32:164-168. 10.1055/s-2007-978615, 10871155.
42. Bowen RS, Gu Y, Zhang Y, Lewis DF, Wang Y. Hypoxia promotes interleukin-6 and -8 but reduces interleukin-10 production by placental trophoblast cells from preeclamptic pregnancies. J Soc Gynecol Investig 2005, 12:428-432. 10.1016/j.jsgi.2005.04.001, 15914040.
43. Jones HN, Jansson T, Powell TL. IL-6 stimulates system a amino acid transporter activity in trophoblast cells through STAT3 and increased expression of SNAT2. Am J Physiol Cell Physiol 2009, 297:C1228-C1235. 10.1152/ajpcell.00195.2009, 19741197.
44. Zhou CC, Irani RA, Dai Y, Blackwell SC, Hicks MJ, Ramin SM, Kellems RE, Xia Y. Autoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsia. J Immunol 2011, 186:6024-6034. 10.4049/jimmunol.1004026, 21482739.
45. Elaraj DM, Weinreich DM, Varghese S, Puhlmann M, Hewitt SM, Carroll NM, Feldman ED, Turner EM, Alexander HR. The role of interleukin 1 in growth and metastasis of human cancer xenografts. Clinic Cancer Res 2006, 12:1088-1096.
46. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y, Dinarello CA, Apte RN. IL-1 is required for tumor invasiveness and angiogenesis. PNAS USA 2003, 100:2645-2650. 10.1073/pnas.0437939100, 151394, 12598651.
47. Carmi Y, Voronov E, Dotan S, Lahat N, Rahat MA, Fogel M, Huszar M, White MR, Dinarello CA, Apte RN. The role of macrophage-derived IL-1 in induction and maintenance of angiogenesis. J Immunol 2009, 183:4705-4714. 10.4049/jimmunol.0901511, 19752225.
48. Coxon A, Bolon B, Estrada J, Kaufman S, Scully S, Rattan A, Duryea D, Hu YL, Rex K, Pacheco E, Van G, Zack D, Feige U. Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis. Arthrit Rheumat 2002, 46:2604-2612.
49. Hellwig-Burgel T, Rutkowski K, Metzen E, Fandrey J, Jelkmann W. Interleukin-1beta and tumor necrosis factor-alpha stimulate DNA binding of hypoxia-inducible factor-1. Blood 1999, 94:1561-1567.
50. Argaw AT, Zhang Y, Snyder BJ, Zhao ML, Kopp N, Lee SC, Raine CS, Brosnan CF, John GR. IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J Immunol 2006, 177:5574-5584.
51. Paulesu L, King A, Loke YW, Cintorino M, Bellizzi E, Boraschi D. Immunohistochemical localization of IL-1 alpha and IL-1 beta in normal human placenta. Lymphokine Cytokine Res 1991, 10:443-448.
52. Molvarec A, Szarka A, Walentin W, Beko G, Karadi I, Prohaszka Z, Rigo J. Serum leptin levels in relation to circulating cytokines, chemokines, adhesion molecules and angiogenic factors in normal pregnancy and preeclampsia. Reprod Biol Endocrinol 2011, 9:124. 10.1186/1477-7827-9-124, 3184629, 21906313.
53. Beceriklisoy HB, Schäfer-Somi S, Kücükaslan I, Agaoglu R, Gültiken N, Ay SS, Kaya D, Aslan S. Cytokines, growth factors and prostaglandin synthesis in the uterus of pregnant and non-pregnant bitches: the features of placental sites. Reprod Domest Anim 2009, 44(Suppl 2):115-119.
54. Devaraj S, Jialal I. Alpha-tocopherol decreases interleukin-1 beta release from activated human monocytes by inhibition of 5-lipoxygenase. Arterioscler Thromb Vasc Biol 1999, 19:1125-1133. 10.1161/01.ATV.19.4.1125, 10195945.
55. Devaraj S, Jialal I. Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients. FRBM 2000, 29:790-792.
56. Nobata Y, Urakaze M, Temaru R, Sato A, Nakamura N, Yamazaki K, Kishida M, Takata M, Kobayashi M. alpha-Tocopherol Inhibits IL-8 synthesis induced by thrombin and high glucose in endothelial cells. Horm Metab Res 2002, 34:49-54. 10.1055/s-2002-20523, 11972286.
57. Zhu MJ, Du M, Nathanielsz PW, Ford SP. Maternal obesity up-regulates inflammatory signaling pathways and enhances cytokine expression in the mid-gestation sheep placenta. Placenta 2010, 31:387-391. 10.1016/j.placenta.2010.02.002, 20185176.
58. Ma Y, Zhu MJ, Zhang L, Hein SM, Nathanielsz PW, Ford SP. Maternal obesity and overnutrition alter fetal growth rate and cotyledonary vascularity and angiogenic factor expression in the ewe. Am J Physiol Regul Integr Comp Physiol 2010, 299:R249-R258. 10.1152/ajpregu.00498.2009, 2904149, 20427725.